Related references
Note: Only part of the references are listed.The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT) A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)
Oluwadamilola M. Fayanju et al.
ANNALS OF SURGERY (2018)
What Drives Patient Choice: Preferences for Approaches to Surgical Treatments for Breast Cancer Beyond Traditional Clinical Benchmarks
Toni Storm-Dickerson et al.
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN (2018)
Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study
Akiko Chiba et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers
Ingeborg J. H. Vriens et al.
EUROPEAN JOURNAL OF CANCER (2017)
An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer
Jesse L. Felts et al.
BREAST JOURNAL (2017)
Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy
Oriana A. Petruolo et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer
W. Truin et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer A Systematic Review and Meta-analysis
Laura M. Spring et al.
JAMA ONCOLOGY (2016)
Decision-Making in the Surgical Treatment of Breast Cancer: Factors Influencing Women's Choices for Mastectomy and Breast Conserving Surgery
Emily Catherine Bellavance et al.
FRONTIERS IN ONCOLOGY (2016)
Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives
Romualdo Barroso-Sousa et al.
ECANCERMEDICALSCIENCE (2016)
Management of Premenopausal Women with Neoadjuvant Endocrine Therapy: A Single-Institution Experience
Thanh U. Barbie et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?
Niamh Conlon et al.
BREAST JOURNAL (2015)
Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics
Amy E. McCart Reed et al.
BREAST CANCER RESEARCH (2015)
Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review
A. Charehbili et al.
CANCER TREATMENT REVIEWS (2014)
Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer
Fausto Petrelli et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Invasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systems
Matthew J. Sikora et al.
STEROIDS (2013)
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer
Esther H. Lips et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Invasive lobular carcinoma: response to neoadjuvant letrozole therapy
J. Michael Dixon et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype-ACOSOG Z1031
Matthew J. Ellis et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Utility of Oncotype DX Risk Estimates in Clinically Intermediate Risk Hormone Receptor-Positive, HER2-Normal, Grade II, Lymph Node-Negative Breast Cancers
Catherine M. Kelly et al.
CANCER (2010)
Invasive lobular carcinoma of the breast: Should this be regarded as a chronic disease?
I. F. Anwar et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Time-Varying Effects of Prognostic Factors Associated With Disease-Free Survival in Breast Cancer
Loki Natarajan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation
Judy C. Boughey et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes
Emad A. Rakha et al.
EUROPEAN JOURNAL OF CANCER (2008)
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Priya Rastogi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: Combined results of 15 International Breast Cancer Study Group clinical trials
Bernhard C. Pestalozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment
Todd M. Tuttle et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas:: a retrospective study on 860 patients from one institution
M. Tubiana-Hulin et al.
ANNALS OF ONCOLOGY (2006)
Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
G Arpino et al.
BREAST CANCER RESEARCH (2004)
Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence
D Coradini et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
